Compare NPCE & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPCE | IPI |
|---|---|---|
| Founded | 1997 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.2M | 534.0M |
| IPO Year | 2021 | 2007 |
| Metric | NPCE | IPI |
|---|---|---|
| Price | $14.15 | $39.47 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 6 | 1 |
| Target Price | $18.33 | ★ $25.00 |
| AVG Volume (30 Days) | 104.7K | ★ 193.7K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.03 | ★ 105.14 |
| EPS | N/A | ★ 1.73 |
| Revenue | $99,986,000.00 | ★ $298,328,000.00 |
| Revenue This Year | $0.90 | $5.01 |
| Revenue Next Year | $24.46 | N/A |
| P/E Ratio | ★ N/A | $22.21 |
| Revenue Growth | ★ 25.13 | 17.13 |
| 52 Week Low | $9.22 | $22.55 |
| 52 Week High | $19.60 | $50.34 |
| Indicator | NPCE | IPI |
|---|---|---|
| Relative Strength Index (RSI) | 46.56 | 49.64 |
| Support Level | $13.75 | $36.28 |
| Resistance Level | $15.33 | $39.09 |
| Average True Range (ATR) | 0.55 | 1.79 |
| MACD | -0.01 | -0.30 |
| Stochastic Oscillator | 27.12 | 30.64 |
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, where the firm's production facilities are located.